The Effect of Imatinib Treatment Duration on the Quality of the Life of Patients with Chronic Myeloid Leukemia
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F13%3A00071569" target="_blank" >RIV/00216224:14110/13:00071569 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.4172/2155-9864.1000167" target="_blank" >http://dx.doi.org/10.4172/2155-9864.1000167</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4172/2155-9864.1000167" target="_blank" >10.4172/2155-9864.1000167</a>
Alternative languages
Result language
angličtina
Original language name
The Effect of Imatinib Treatment Duration on the Quality of the Life of Patients with Chronic Myeloid Leukemia
Original language description
Purpose: The objective of this study was to evaluate the quality of life (QL) as well as the frequency and severity of depression in patients with chronic phase chronic myeloid leukemia (CP-CML) in relation to the duration of Imatinib treatment. Methods:A detailed analysis of 56 adult patients with CP CML divided into groups according to the length of Imatinib treatment was performed as follows: Group A (n=28)- patients treated for 15 months (median); and Group B (n=28)-patients treated for 50 months (median). All used questionnaires EORTC QLQ-C30 (version 2), SF 36 and BDI were localized and validated. Results: The results from the QL questionnaires found a trend in the improvement in the QL of patients treated with Imatinib for 50 months (median) compared to patients treated for 15 months (median) only. However, a statistically significant improvement in the QL of patients with longer Imatinib treatment was found only in patients without co-existing invalidity and/or rheumatic disea
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Blood Disorders & Transfusion
ISSN
2155-9864
e-ISSN
—
Volume of the periodical
4
Issue of the periodical within the volume
6
Country of publishing house
GB - UNITED KINGDOM
Number of pages
5
Pages from-to
1000167
UT code for WoS article
—
EID of the result in the Scopus database
—